Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology cash
Cash and short-term investments held at the end of each period.
Nexalin Technology's cash was $1.00M at Jun 30, 2026. For fiscal 2025 it was $3.72M, up 7.0% from the year before. The highest annual figure on record is $6.99M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.72M | +7.0% |
| FY2024 | Dec 31, 2024 | $3.48M | +18.0% |
| FY2023 | Dec 31, 2023 | $2.95M | -57.8% |
| FY2022 | Dec 31, 2022 | $6.99M | +956.8% |
| FY2021 | Dec 31, 2021 | $661.78K | +743.7% |
| FY2020 | Dec 31, 2020 | $78.44K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.00M | -82.7% |
| Q1 FY2026 | Mar 31, 2026 | $2.71M | +32.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.72M | +7.0% |
| Q3 FY2025 | Sep 30, 2025 | $4.35M | -5.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.79M | +582.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.05M | -4.3% |
| Q4 FY2024 | Dec 31, 2024 | $3.48M | +18.0% |
| Q3 FY2024 | Sep 30, 2024 | $4.59M | -2.2% |
| Q2 FY2024 | Jun 30, 2024 | $848.80K | -84.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.14M | -69.3% |
| Q4 FY2023 | Dec 31, 2023 | $2.95M | -62.5% |
| Q2 FY2023 | Jun 30, 2023 | $4.70M | +1512.1% |
| Q1 FY2023 | Mar 31, 2023 | $5.47M | +1093.3% |
| Q4 FY2022 | Dec 31, 2022 | $6.99M | +956.8% |
| Q3 FY2022 | Sep 30, 2022 | $7.86M | +5664.4% |
| Q2 FY2022 | Jun 30, 2022 | $291.34K | +271.4% |
| Q1 FY2022 | Mar 31, 2022 | $458.61K | – |
| Q4 FY2021 | Dec 31, 2021 | $661.78K | – |
| Q3 FY2021 | Sep 30, 2021 | $136.43K | – |
| Q4 FY2020 | Dec 31, 2020 | $78.44K | – |
See a number that looks wrong?